Literature DB >> 9388735

> or = 95% of xanthine oxidase in human milk is present as the demolybdo form, lacking molybdopterin.

B Godber1, S Sanders, R Harrison, R Eisenthal, R C Bray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9388735     DOI: 10.1042/bst025519s

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  7 in total

Review 1.  Role of xanthine oxidoreductase as an antimicrobial agent.

Authors:  Hannah M Martin; John T Hancock; Vyv Salisbury; Roger Harrison
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

2.  Expression of Drosophila melanogaster xanthine dehydrogenase in Aspergillus nidulans and some properties of the recombinant enzyme.

Authors:  Benjamin Adams; David J Lowe; Andrew T Smith; Claudio Scazzocchio; Stephane Demais; Robert C Bray
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

3.  Suicide inactivation of xanthine oxidoreductase during reduction of inorganic nitrite to nitric oxide.

Authors:  B L Godber; J J Doel; T A Goult; R Eisenthal; R Harrison
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

4.  Functional regulation of xanthine oxidoreductase expression and localization in the mouse mammary gland: evidence of a role in lipid secretion.

Authors:  J L McManaman; C A Palmer; R M Wright; M C Neville
Journal:  J Physiol       Date:  2002-12-01       Impact factor: 5.182

5.  Molecular characterization of human xanthine oxidoreductase: the enzyme is grossly deficient in molybdenum and substantially deficient in iron-sulphur centres.

Authors:  Benjamin L J Godber; Guenter Schwarz; Ralf R Mendel; David J Lowe; Robert C Bray; Robert Eisenthal; Roger Harrison
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

Review 6.  Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

Authors:  Cristine E Berry; Joshua M Hare
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

Review 7.  Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout.

Authors:  Takeshi Nishino; Ken Okamoto
Journal:  J Biol Inorg Chem       Date:  2014-12-12       Impact factor: 3.358

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.